tradingkey.logo
搜尋

VivoSim Labs Ord Shs

VIVS
添加自選
0.155USD
+0.026+20.16%
收盤 11-11 16:00(美東)
2.57M總市值
0.09本益比TTM
盤後交易 19:18 (美東)0.150USD-0.001-0.66%

關於 VivoSim Labs Ord Shs 公司

VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company's 3D human tissue platform is multifaceted. The Company has expertise in 3D organoids, such as spheroids, and has made advances in proprietary cell culture techniques including ratios, components and conditions.

VivoSim Labs Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

VivoSim Labs Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Keith E. Murphy
Mr. Keith E. Murphy
Executive Chairman of the Board, Corporate Secretary
Executive Chairman of the Board, Corporate Secretary
27.09K
+55.37%
Mr. Douglas Jay Cohen
Mr. Douglas Jay Cohen
Lead Independent Director
Lead Independent Director
20.90K
+71.77%
Mr. Tony Lialin
Mr. Tony Lialin
Chief Commercial Officer
Chief Commercial Officer
20.00K
--
Ms. Alison Tjosvold Milhous
Ms. Alison Tjosvold Milhous
Independent Director
Independent Director
19.90K
+75.38%
Mr. David Gobel
Mr. David Gobel
Independent Director
Independent Director
15.00K
--
Mr. Adam K. Stern
Mr. Adam K. Stern
Independent Director
Independent Director
--
--
Mr. Norman Staskey
Mr. Norman Staskey
President, Chief Financial Officer
President, Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Keith E. Murphy
Mr. Keith E. Murphy
Executive Chairman of the Board, Corporate Secretary
Executive Chairman of the Board, Corporate Secretary
27.09K
+55.37%
Mr. Douglas Jay Cohen
Mr. Douglas Jay Cohen
Lead Independent Director
Lead Independent Director
20.90K
+71.77%
Mr. Tony Lialin
Mr. Tony Lialin
Chief Commercial Officer
Chief Commercial Officer
20.00K
--
Ms. Alison Tjosvold Milhous
Ms. Alison Tjosvold Milhous
Independent Director
Independent Director
19.90K
+75.38%
Mr. David Gobel
Mr. David Gobel
Independent Director
Independent Director
15.00K
--
Mr. Adam K. Stern
Mr. Adam K. Stern
Independent Director
Independent Director
--
--

常見問題

VivoSim Labs Ord Shs的前五大股東是誰?

VivoSim Labs Ord Shs的前五大股東如下:Mr. Keith E. Murphy
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有